Yüklüyor......
Experimental Pharmacological Agents for the Treatment of Primary Biliary Cholangitis
The standard therapy for primary biliary cholangitis (PBC) is ursodeoxycholic acid (UDCA) which has shown to improve hepatic biochemistry, delay histological progression and improve transplant-free survival. Approximately 30–40% of patients do not respond or are intolerant to UDCA. Obeticholic acid,...
Kaydedildi:
| Yayımlandı: | J Exp Pharmacol |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7751712/ https://ncbi.nlm.nih.gov/pubmed/33364858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S267375 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|